EST
AVNS icon

EA Series Trust’s Avanos Medical AVNS Stock Holding History

EA Series Trust’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$3.51M Buy
+137,195
New +$3.61M 0.12% 210

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

EA Series Trust's AVNS Position: Q2 2023 in Review

EA Series Trust opened a new position in Avanos Medical (AVNS) in Q2 2023: 137,195 shares worth $3.51M. The stake represents 0.12% of the portfolio and ranks #210 among its holdings.

274 funds tracked by Wall St. Rank hold AVNS as of Q2 2023.

  • EA Series Trust held 137,195 shares of Avanos Medical worth $3.51M as of Q2 2023.
  • Avanos Medical was a new EA Series Trust position in Q2 2023.
  • Avanos Medical made up 0.12% of EA Series Trust's portfolio in Q2 2023, its #210 holding.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2023.

Based on EA Series Trust's 13F filing for Q2 2023, filed 27 Jul 2023.